Ignite Creation Date:
2024-05-06 @ 10:15 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03204734
Status:
UNKNOWN
Last Update Posted:
2017-07-02
First Post:
2017-06-24
Brief Title:
Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2017-06-24
First Submit QC Date:
June 27 2017
Study First Post Date:
2017-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-27
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL